Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca

Clinical trial NCT02957968 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02957968
Sponsor: Virginia Commonwealth University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Adenocarcinoma Estrogen Receptor- Negative Breast Cancer Estrogen Receptor-positive Breast Cancer HER2/Neu Negative Invasive Breast Carcinoma Progesterone Receptor Negative Progesterone Receptor Positive Tumor Stage II Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer

Start date: 2017-01-24
Primary completion: 2022-08-04
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.